Esposito Pamela bought KYMR
March 20, 2026 · Form 4 insider transaction
Esposito Pamela bought 2,500 shares of Kymera Therapeutics, Inc. at $49.10 per share, a transaction worth $122.8K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,500
Price
$49.10
Total value
$122.8K
InsiderEsposito Pamela
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 20, 2026
Filing dateMarch 20, 2026
Shares owned after2,500
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person.